Abstract
Background
Patients’ beliefs and attitudes towards a treatment can affect treatment response. In unblinded trials this can affect outcomes.
Aims
The aim of this analysis was to examine the association between treatment preference and expectation, and outcome in a trial of pain treatments.
Methods
In a randomised trial (ISRCTN67013851) of four treatments for chronic widespread pain, participants were asked which they would prefer, and what improvement they expect from each. The proportion of participants reporting positive health outcomes at three time-points after treatment were compared between those matched or unmatched with their preference, and between those with and without expectation for improvement. Odds ratios were calculated adjusted for baseline characteristics associated with preference and expectation.
Results
442 participants were recruited to the trial (69.5% female). The proportion reporting positive outcome among participants matched to their preference compared to those unmatched was: 33.3% vs 34.4% at end of treatment (adjusted OR 0.80, 95% CI 0.44–1.46), 34.4% vs 29.0% at 3 months (aOR 1.23, 0.67–2.26), and 34.8% vs 30.3% at 2 years (aOR 1.31, 0.70–2.46). The proportion of participants reporting positive outcome among those expecting improvement compared to those not was: 36.6% vs 15.0% at end of treatment (aOR 2.03, 1.07–3.85), 34.1% vs 13.2% at 3 months (aOR 2.31, 1.22–4.38), and 32.8% vs 19.1% at 2 years (aOR 1.16, 0.67–2.36).
Conclusions
Treatment preference had no clear effect on outcomes, but expectation did. These results could inform future approaches to management, while researchers assessing treatments should take into account this expectation effect.
Patients’ beliefs and attitudes towards a treatment can affect treatment response. In unblinded trials this can affect outcomes.
Aims
The aim of this analysis was to examine the association between treatment preference and expectation, and outcome in a trial of pain treatments.
Methods
In a randomised trial (ISRCTN67013851) of four treatments for chronic widespread pain, participants were asked which they would prefer, and what improvement they expect from each. The proportion of participants reporting positive health outcomes at three time-points after treatment were compared between those matched or unmatched with their preference, and between those with and without expectation for improvement. Odds ratios were calculated adjusted for baseline characteristics associated with preference and expectation.
Results
442 participants were recruited to the trial (69.5% female). The proportion reporting positive outcome among participants matched to their preference compared to those unmatched was: 33.3% vs 34.4% at end of treatment (adjusted OR 0.80, 95% CI 0.44–1.46), 34.4% vs 29.0% at 3 months (aOR 1.23, 0.67–2.26), and 34.8% vs 30.3% at 2 years (aOR 1.31, 0.70–2.46). The proportion of participants reporting positive outcome among those expecting improvement compared to those not was: 36.6% vs 15.0% at end of treatment (aOR 2.03, 1.07–3.85), 34.1% vs 13.2% at 3 months (aOR 2.31, 1.22–4.38), and 32.8% vs 19.1% at 2 years (aOR 1.16, 0.67–2.36).
Conclusions
Treatment preference had no clear effect on outcomes, but expectation did. These results could inform future approaches to management, while researchers assessing treatments should take into account this expectation effect.
Original language | English |
---|---|
Pages (from-to) | 161-170 |
Number of pages | 10 |
Journal | Canadian Journal of Pain |
Volume | 1 |
Issue number | 1 |
Early online date | 11 Oct 2017 |
DOIs | |
Publication status | Published - 2017 |
Keywords
- placebo response
- treatment preference
- expectation
- randomised controlled trials
- treatment effect
- non-specific effects